Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice
S. Fiorentino1,4, M. Chopin1, H. Dastot1, N. Boissel2, M. Reboul1, L. Legrès1, A. Janin1, P. Aplan3, F. Sigaux1, Armelle Regnault1
European Cytokine Network, Vol.16, No.4, pp. 300-308, 2005
Abstract Acute lymphoblastic leukemia (ALL) is the most common cancer in children. In recent years, the
outcome has been globally improved by current therapies, but it remains poor in patients with high, persistent
residual disease following the first course of chemotherapy, prompting evaluation of the possible beneficial effects
of immunotherapy protocols. In this study, we hypothesized that the disruption of two immunoregulatory
pathways controlling the auto-reactive T cell response might synergize with dendritic cell-based immunotherapy
of the disease, which is considered to be poorly immunogenic. In this study, we used TAL1xLMO1 leukemia cells
adoptively transferred in… More >